Catherine Helene Trepanier - Publications

Affiliations: 
2012 Pharmacology University of Toronto, Toronto, ON, Canada 

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Trepanier C, Lei G, Xie YF, MacDonald JF. Group II metabotropic glutamate receptors modify N-methyl-D-aspartate receptors via Src kinase. Scientific Reports. 3: 926. PMID 23378895 DOI: 10.1038/Srep00926  0.73
2012 Yang K, Trepanier C, Sidhu B, Xie YF, Li H, Lei G, Salter MW, Orser BA, Nakazawa T, Yamamoto T, Jackson MF, Macdonald JF. Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases. The Embo Journal. 31: 805-16. PMID 22187052 DOI: 10.1038/Emboj.2011.453  0.689
2012 Trepanier CH, Jackson MF, MacDonald JF. Regulation of NMDA receptors by the tyrosine kinase Fyn. The Febs Journal. 279: 12-9. PMID 21985328 DOI: 10.1111/J.1742-4658.2011.08391.X  0.718
2011 Yang K, Belrose J, Trepanier CH, Lei G, Jackson MF, MacDonald JF. Fyn, a potential target for Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 27: 243-52. PMID 21799250 DOI: 10.3233/Jad-2011-110353  0.604
2011 Li HB, Jackson MF, Yang K, Trepanier C, Salter MW, Orser BA, Macdonald JF. Plasticity of synaptic GluN receptors is required for the Src-dependent induction of long-term potentiation at CA3-CA1 synapses. Hippocampus. 21: 1053-61. PMID 20865743 DOI: 10.1002/Hipo.20818  0.699
2010 Trepanier CH, Milgram NW. Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy? Journal of Alzheimer's Disease : Jad. 21: 1089-99. PMID 21504126 DOI: 10.3233/Jad-2010-090667  0.332
2009 Yang K, Trepanier CH, Li H, Beazely MA, Lerner EA, Jackson MF, MacDonald JF. Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission. Hippocampus. 19: 779-89. PMID 19173226 DOI: 10.1002/Hipo.20559  0.705
2009 Beazely MA, Lim A, Li H, Trepanier C, Chen X, Sidhu B, Macdonald JF. Platelet-derived growth factor selectively inhibits NR2B-containing N-methyl-D-aspartate receptors in CA1 hippocampal neurons. The Journal of Biological Chemistry. 284: 8054-63. PMID 19106110 DOI: 10.1074/Jbc.M805384200  0.644
Show low-probability matches.